Good News For GNVC, ACRS On Track, TBRA Tanks, FDA Says No To OCUL

Shares of GenVec Inc. (GNVC) rose over 50% in extended trading on Monday after being notified that the FDA has lifted the clinical hold on the Phase 1/2 clinical trial of CGF166 in patients with severe to profound hearing loss.

from RTT - Biotech http://ift.tt/2a5VDyH
via IFTTT